Bluebirdbio stock.

Get the latest bluebird bio Inc. (BLUE) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Biotech and Pharma bluebird bio Has Good News on Its Gene Therapies Dec. 13, 2021 at 12:16 p.m. ET by Barron's 2seventy bio started at outperform with $40 stock price target at [email protected]. Investor Contacts. Courtney O’Leary. Investor Relations (978) 621-7347. [email protected]. stock quote stock sub menu. Stock Quote; Stock Chart (Common Stock) Exchange (US Dollar) Price: Change (%) Volume: Today's Open: Previous Close: Intraday High: Intraday Low:Apple Inc. Common Stock. $191.6541 +1.9641 +1.04%. bluebird bio, Inc. Common Stock (BLUE) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global ...bluebird bio Stock Up 11.5 % NASDAQ BLUE traded up $0.44 during trading on Friday, reaching $4.26. 5,100,895 shares of the stock traded hands, compared to its average volume of 4,113,761.

Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... bluebird bio, Inc. …As for liquidity, bluebird bio reported ~$227M in cash, cash equivalents, marketable securities, and restricted cash as of 2022 year-end and indicated a cash runway until Q4 2024, including ~$45M ...

Even Bluebird Bio (NASDAQ:BLUE) is waiting on a US FDA decision on its sickle cell treatment, lovo-cel. With a decision date set for Dec. 20 , BLUE is already gaining momentum, running from about ...Buy or Hold candidate since Nov 15, 2023 Gain 16.72% PDF. No changes to the price of bluebird bio stock on the last trading day (Tuesday, 28th Nov 2023). During the last trading day the stock fluctuated 5.19% from a day low at $3.66 to a day high of $3.85. The price has risen in 6 of the last 10 days and is up by 27.15% over the past 2 weeks.

Bluebird bio will cut 30% of its workforce in the hopes of extending its cash runway into the first half of 2023, the company revealed Tuesday. As of Jan. 31, the Massachusetts biotech counted 518 ...bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. With a dedicated focus on severe genetic diseases, bluebird has industry-leading programs for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases.Bluebird bio stock price target cut to $86 from $172 at Evercore ISI. 0. Canada Goose downgraded to buy from strong buy at CFRA. 0. Canada Goose stock price target cut to $50 from $65 at CFRA. 0. Children's Place downgraded as e-commerce puts margins at …Jun 30, 2023 · Let's look at Bluebird Bio (BLUE 2.64%). Per Wall Street's analysts, its shares could rise 118% by this time next year despite losing 51% of their value so far in 2023.

Feb 16, 2021 · On Tuesday morning, gene therapy specialist bluebird bio ( BLUE 2.64%) announced the temporary suspension of two of its clinical trials for LentiGlobin, an experimental gene therapy for sickle ...

AnaptysBio Inc. 14.20. UNCH. UNCH. Get bluebird bio Inc (BLUE:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... bluebird bio, Inc. …Bluebird Bio Inc (NASDAQ: BLUE) shares are trading lower Monday. The stock initially surged in premarket trading following the U.S. Food and Drug Administration's accelerated approval of ...As at March 2023, bluebird bio had cash of US$318m and no debt. In the last year, its cash burn was US$328m. Therefore, from March 2023 it had roughly 12 months of cash runway. To be frank, this ...The major restructuring is meant to revive the fortunes of both divisions, which have struggled to capitalize on Bluebird's once-leading position in the emerging fields of cell and gene therapy. A succession of setbacks and delays have weighed on the company's stock price, which, at less than $50 per share, is about one-fifth its March 2018 peak.Bluebird Bio (BLUE) Even Bluebird Bio (NASDAQ: BLUE) is waiting on a US FDA decision on its sickle cell treatment, lovo-cel. With a decision date set for Dec. 20, BLUE is already gaining momentum ...

SOMERVILLE, Mass., January 18, 2023--bluebird bio, Inc. (Nasdaq: BLUE) ("bluebird") today announced that it has commenced an underwritten public offering of 20,000,000 shares of its common stock ...bluebird bio Inc (BLUE) stock is trading at $5.15 as of 3:06 PM on Friday, Mar 3, a rise of $0.20, or 3.94% from the previous closing price of $4.95. The stock has traded between $4.83 and $5.23 so far today. Volume today is light. So far 1,320,042 shares have traded compared to average volume of 3,101,153 shares.Target values for the price of one bluebird bio share for Nov 2025. The weighted average target price per bluebird bio share in Nov 2025 is: 8.72. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 19.746% volatility is expected. Pessimistic target level: 7.95. Optimistic target level: 9.91.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Bluebird Bio ( BLUE) is trending after the U.S. Food and Drug Administration (FDA) lifted its hold on the company’s sickle cell disease treatment. Bluebird Bio says it’s on track to submit a ...Overview News bluebird bio Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.74 Market Cap $425.32 M Shares …View the latest bluebird bio Inc. (BLUE) stock price, news, historical charts, analyst ratings and financial information from WSJ.

The last 12 months haven't been kind to the likes of gene editing stocks like CRISPR Therapeutics (CRSP 2.88%) and Bluebird Bio (BLUE 11.52%). Whereas CRISPR's shares fell by 31%, Bluebird's are ...

Latest BLUE News. View. bluebird bio (BLUE, $4.26) RSI Indicator left the overbought zone on December 01, 2023. Tickeron - Stocks • about 12 hours ago. bluebird bio (BLUE, $3.66) Stochastic Oscillator left the overbought zone on November 21, 2023. Tickeron - Stocks • 11 days ago. bluebird bio Target of Unusually Large Options Trading ... bluebird bio, Inc. BLUE Bluebird Bio signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. The company’s stock has a 52-week low of $2.78.Bluebird Bio could soon earn approval for two key gene-editing therapies. However, the company does face severe financial troubles. Bluebird's stock is risky, but the rewards could be huge. Motley ...13 thg 6, 2022 ... Bluebird Bio Stock Set for Largest One-Day Gain in Eight Years ... Bluebird Bio stock was flying high Monday after an advisory committee of the ...Target values for the price of one bluebird bio share for Nov 2025. The weighted average target price per bluebird bio share in Nov 2025 is: 8.72. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 19.746% volatility is expected. Pessimistic target level: 7.95. Optimistic target level: 9.91.Bluebird Bio drives gene therapy stocks higher after FDA review. Jun. 07, 2022 3:59 PM ET bluebird bio, Inc. ... Bluebird bio has posted its best intraday gain since 2014.Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share …

bluebird bio, Inc. BLUE Bluebird Bio signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. The company’s stock has a 52-week low of $2.78.

As of September 4, 2023, Profund Advisors LLC has acquired a new stake in bluebird bio, Inc. (NASDAQ:BLUE), according to the latest Form 13F filing with the Securities & Exchange Commission. The firm reportedly purchased 297,018 shares of bluebird bio’s stock during the first quarter, with an estimated value of approximately $945,000.

Jun 29, 2023 · Bluebird Bio. Market Cap. $425M. Today's Change. Current Price. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley Fool’s ... Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share price if it lands this historic approval.Bluebird Bio has two advantages over CRISPR Therapeutics that could allow its stock to soar fivefold faster. First, Bluebird is much smaller -- small-cap stocks tend to be capable of more ...stock quote. Stock Quote. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Patients & Advocacy. Investors & Media. [email protected]. …View bluebird bio, Inc BLUE investment & stock information. Get the latest bluebird bio, Inc BLUE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Comprehensive suite of tools for trading and investing in biotech stocks. FDA Calendar, PDUFA Date Calendar, Biotech Company Screener and Database and much moreSummary. bluebird works as a biotech company developing curative gene therapies to save lives. Concerns over its cash runway and clinical trials are overblown, with the stock near all-time lows ...Mar 10, 2022 · Shares of Bluebird Bio ( BLUE 0.61%) were sinking 10.4% this week as of the market close on Thursday, according to data from S&P Global Market Intelligence. The decline came after the company ... Nov 4, 2023 · Bluebird Bio has experienced a barrage of issues in the past five years. The biotech has a potential approval on the way that could help it rebound. Even so, the company remains a risky stock to ... bluebird bio Stock (NASDAQ: BLUE) stock price, news, charts, stock research, profile.Bluebird bio stock price target cut to $86 from $172 at Evercore ISI. 0. Canada Goose downgraded to buy from strong buy at CFRA. 0. Canada Goose stock price target cut to $50 from $65 at CFRA. 0. Children's Place downgraded as e-commerce puts margins at …On average, Wall Street analysts predict. that Bluebird Bio's share price could reach $7.64 by Nov 8, 2024. The average Bluebird Bio stock price prediction forecasts a potential upside of 96.45% from the current BLUE share price of $3.89.

Earnings for bluebird bio are expected to decrease in the coming year, from ($1.81) to ($1.84) per share. bluebird bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off prior year's report dates. Read More.http://www.bluebirdbio.com. External link for bluebird bio. Industry: Biotechnology ... Stock. BLUE. December 2, 2023. NASDAQ. 20 minutes delay. $4.26. 0.44 ( ...Bluebird bio's blood disorder treatment demonstrates "clinically meaningful" benefit in patients, staff reviewers at the U.S. Food and Drug Administration said in briefing documents published on ...Instagram:https://instagram. best broker to trade gold in uso realtyglobal cord bloodwell canada Apr 6, 2023 · The case for buying the dip isn't exactly a slam dunk. With the stock down 52% in the last three months, Bluebird Bio ( BLUE -1.28%) shareholders are bound to be feeling pretty antsy. Between the ... what are the best stocks to day tradeinsurance for mobile phones Feb 24, 2023 · The market expects Bluebird Bio (BLUE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2022. This widely-known consensus ... bluebird bio, Inc. (BLUE) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. As of 03:57PM EST. Market open. See bluebird bio, Inc. (BLUE) stock analyst estimates, including earnings and ... buys broken iphones To say that biotech Bluebird Bio (BLUE 12.50%) has significantly lagged the market in the past year would be an understatement. ... Why Bluebird Bio Stock Soared 7% Higher on Tuesday.Gene therapy developer bluebird bio ( NASDAQ: BLUE) announced an agreement with Jefferies on Tuesday to sell shares of the company's common stock to raise $125M in gross proceeds. The transaction ...bluebird bio, Inc. Common Stock (BLUE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.